Michael Pelli­ni has just joined Bill Maris at Sec­tion 32 — fo­cused on pa­tient care and drug de­vel­op­ment

Michael Pelli­ni has just jumped in­to a se­nior role at one of the most in­trigu­ing new ven­ture funds in the bio­phar­ma/health­care world. The for­mer CEO …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.